Cargando…

PET/MRI enables simultaneous in vivo quantification of β-cell mass and function

Non-invasive imaging of β-cells represents a desirable preclinical and clinical tool to monitor the change of β-cell mass and the loss of function during pre-diabetic stages. Although it is widely accepted that manganese (Mn) ions are actively gated by voltage-dependent calcium channels (VDCC) in re...

Descripción completa

Detalles Bibliográficos
Autores principales: Michelotti, Filippo C., Bowden, Gregory, Küppers, Astrid, Joosten, Lieke, Maczewsky, Jonas, Nischwitz, Volker, Drews, Gisela, Maurer, Andreas, Gotthardt, Martin, Schmid, Andreas M., Pichler, Bernd J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929626/
https://www.ncbi.nlm.nih.gov/pubmed/31903128
http://dx.doi.org/10.7150/thno.33410
_version_ 1783482739030228992
author Michelotti, Filippo C.
Bowden, Gregory
Küppers, Astrid
Joosten, Lieke
Maczewsky, Jonas
Nischwitz, Volker
Drews, Gisela
Maurer, Andreas
Gotthardt, Martin
Schmid, Andreas M.
Pichler, Bernd J.
author_facet Michelotti, Filippo C.
Bowden, Gregory
Küppers, Astrid
Joosten, Lieke
Maczewsky, Jonas
Nischwitz, Volker
Drews, Gisela
Maurer, Andreas
Gotthardt, Martin
Schmid, Andreas M.
Pichler, Bernd J.
author_sort Michelotti, Filippo C.
collection PubMed
description Non-invasive imaging of β-cells represents a desirable preclinical and clinical tool to monitor the change of β-cell mass and the loss of function during pre-diabetic stages. Although it is widely accepted that manganese (Mn) ions are actively gated by voltage-dependent calcium channels (VDCC) in response to glucose metabolism, little is known on its specificity in vivo for quantification of islet β-cell function using Mn and magnetic resonance imaging (MRI). On the other hand, glucagon-like-peptide-1 receptor (GLP-1R) represents a validated target for the estimation of β-cell mass using radiolabeled exendin-4 (Ex4) and positron emission tomography (PET). However, a multiparametric imaging workflow revealing β-cell mass and function quantitatively is still missing. Methods: We developed a simultaneous PET/MRI protocol to comprehensively quantify in vivo changes in β-cell mass and function by targeting, respectively, GLP-1R and VDCC coupled with insulin secretion. Differences in the spatial distribution of Mn and radiolabeled Ex4 were monitored overtime in native and transgenic pancreata, characterized by spontaneous pancreatic neuroendocrine tumor development. Follow-up with mass spectrometry imaging (MSI) and autoradiography allowed the ex vivo validation of the specificity of Mn and PET tracer uptake and the detection of endogenous biometals, such as calcium and zinc, throughout the endocrine and exocrine pancreas. Results: Our in vivo data based on a volumetric PET/MRI readout for native pancreata and insulinomas connects uptake of Mn measured at early imaging time points to high non-specific binding by the exocrine tissue, while specific retention was only found 24 h post injection. These results are supported by cross-validation of the spatial distribution of exogenous (55)Mn and endogenous (44)Ca and (64)Zn as well with the specific internalization of the radiolabeled peptide targeting GLP-1R. Conclusion: Simultaneous PET/MR imaging of the pancreas enabled the comprehensive in vivo quantification of β-cell function and mass using Mn and radiolabeled Ex4. Most important, our data revealed that only late time-point measurements reflect the Mn uptake in the islet β-cells, while early time points detect non-specific accumulation of Mn in the exocrine pancreas.
format Online
Article
Text
id pubmed-6929626
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-69296262020-01-04 PET/MRI enables simultaneous in vivo quantification of β-cell mass and function Michelotti, Filippo C. Bowden, Gregory Küppers, Astrid Joosten, Lieke Maczewsky, Jonas Nischwitz, Volker Drews, Gisela Maurer, Andreas Gotthardt, Martin Schmid, Andreas M. Pichler, Bernd J. Theranostics Research Paper Non-invasive imaging of β-cells represents a desirable preclinical and clinical tool to monitor the change of β-cell mass and the loss of function during pre-diabetic stages. Although it is widely accepted that manganese (Mn) ions are actively gated by voltage-dependent calcium channels (VDCC) in response to glucose metabolism, little is known on its specificity in vivo for quantification of islet β-cell function using Mn and magnetic resonance imaging (MRI). On the other hand, glucagon-like-peptide-1 receptor (GLP-1R) represents a validated target for the estimation of β-cell mass using radiolabeled exendin-4 (Ex4) and positron emission tomography (PET). However, a multiparametric imaging workflow revealing β-cell mass and function quantitatively is still missing. Methods: We developed a simultaneous PET/MRI protocol to comprehensively quantify in vivo changes in β-cell mass and function by targeting, respectively, GLP-1R and VDCC coupled with insulin secretion. Differences in the spatial distribution of Mn and radiolabeled Ex4 were monitored overtime in native and transgenic pancreata, characterized by spontaneous pancreatic neuroendocrine tumor development. Follow-up with mass spectrometry imaging (MSI) and autoradiography allowed the ex vivo validation of the specificity of Mn and PET tracer uptake and the detection of endogenous biometals, such as calcium and zinc, throughout the endocrine and exocrine pancreas. Results: Our in vivo data based on a volumetric PET/MRI readout for native pancreata and insulinomas connects uptake of Mn measured at early imaging time points to high non-specific binding by the exocrine tissue, while specific retention was only found 24 h post injection. These results are supported by cross-validation of the spatial distribution of exogenous (55)Mn and endogenous (44)Ca and (64)Zn as well with the specific internalization of the radiolabeled peptide targeting GLP-1R. Conclusion: Simultaneous PET/MR imaging of the pancreas enabled the comprehensive in vivo quantification of β-cell function and mass using Mn and radiolabeled Ex4. Most important, our data revealed that only late time-point measurements reflect the Mn uptake in the islet β-cells, while early time points detect non-specific accumulation of Mn in the exocrine pancreas. Ivyspring International Publisher 2020-01-01 /pmc/articles/PMC6929626/ /pubmed/31903128 http://dx.doi.org/10.7150/thno.33410 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Michelotti, Filippo C.
Bowden, Gregory
Küppers, Astrid
Joosten, Lieke
Maczewsky, Jonas
Nischwitz, Volker
Drews, Gisela
Maurer, Andreas
Gotthardt, Martin
Schmid, Andreas M.
Pichler, Bernd J.
PET/MRI enables simultaneous in vivo quantification of β-cell mass and function
title PET/MRI enables simultaneous in vivo quantification of β-cell mass and function
title_full PET/MRI enables simultaneous in vivo quantification of β-cell mass and function
title_fullStr PET/MRI enables simultaneous in vivo quantification of β-cell mass and function
title_full_unstemmed PET/MRI enables simultaneous in vivo quantification of β-cell mass and function
title_short PET/MRI enables simultaneous in vivo quantification of β-cell mass and function
title_sort pet/mri enables simultaneous in vivo quantification of β-cell mass and function
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929626/
https://www.ncbi.nlm.nih.gov/pubmed/31903128
http://dx.doi.org/10.7150/thno.33410
work_keys_str_mv AT michelottifilippoc petmrienablessimultaneousinvivoquantificationofbcellmassandfunction
AT bowdengregory petmrienablessimultaneousinvivoquantificationofbcellmassandfunction
AT kuppersastrid petmrienablessimultaneousinvivoquantificationofbcellmassandfunction
AT joostenlieke petmrienablessimultaneousinvivoquantificationofbcellmassandfunction
AT maczewskyjonas petmrienablessimultaneousinvivoquantificationofbcellmassandfunction
AT nischwitzvolker petmrienablessimultaneousinvivoquantificationofbcellmassandfunction
AT drewsgisela petmrienablessimultaneousinvivoquantificationofbcellmassandfunction
AT maurerandreas petmrienablessimultaneousinvivoquantificationofbcellmassandfunction
AT gotthardtmartin petmrienablessimultaneousinvivoquantificationofbcellmassandfunction
AT schmidandreasm petmrienablessimultaneousinvivoquantificationofbcellmassandfunction
AT pichlerberndj petmrienablessimultaneousinvivoquantificationofbcellmassandfunction